Analysis of adverse reactions of antihypertensive drugs registered in the Republic of Crimea for the period 2011-2016

The aim of study was to analyze and investigate the severity of adverse reactions (AR) on drugs used for arterial hypertension treatment in patients living in the Republic of Crimea for the period 2011—2016.Materials and methods. We studied notification cards about AR registered in the regional data...

Full description

Bibliographic Details
Main Authors: A. V. Matveev, A. E. Krasheninnikov, E. A. Egorova, A. G. Dormidor
Format: Article
Language:Russian
Published: ABV-press 2019-04-01
Series:Klinicist
Subjects:
Online Access:https://klinitsist.abvpress.ru/Klin/article/view/367
_version_ 1797855599687368704
author A. V. Matveev
A. E. Krasheninnikov
E. A. Egorova
A. G. Dormidor
author_facet A. V. Matveev
A. E. Krasheninnikov
E. A. Egorova
A. G. Dormidor
author_sort A. V. Matveev
collection DOAJ
description The aim of study was to analyze and investigate the severity of adverse reactions (AR) on drugs used for arterial hypertension treatment in patients living in the Republic of Crimea for the period 2011—2016.Materials and methods. We studied notification cards about AR registered in the regional database of spontaneous messages ARCADe. We analyzed 211 notification cards about AR in patients with proven arterial hypertension diagnosis (ICD code П0—П5).Results. Drugs from the groups of angiotensin-converting enzyme inhibitors and slow calcium channel blockers most often cause AR, among them enalapril and amlodipine are the absolute leaders. AR occurred less frequently in application of drugs from the groups of в-blockers and angiotensin IIreceptor blockers. The study of the clinical manifestations of AR showed that most of them were allergic reactions of varying severity (skin itch, urticaria, swelling of lips, eyelids, tongue). The number of such cases was 70 (33.2 %) from all registered cases of AR on antihypertensive drugs. Examination of the outcomes of AR in patients taking antihypertensive drugs showed that the development of temporary disability was observed in 19 (9 %) cases, the hospitalization of outpatients as a result of AR development on drugs was required in 7 (3.3 %) cases, and in 2 cases patients had to prolong hospitalization. Life-threatening conditions in the form of Quincke’s edema were reported in 13patients. In the remaining 170 (80.6 %) cases AR were not serious and did not cause the above consequences. Assessment of AR severity revealed that mild AR were most common, much less often antihypertensive drugs caused severe AR (the incidence ranged from 5 to 13 %, depending on the method for severity assessment).Conclusion. The obtained results confirm our previously published data that in the structure of AR on antihypertensive drugs, bulk of the reports associated with angiotensin-converting enzyme inhibitors. Most often antihypertensive drugs caused mild AR.
first_indexed 2024-04-09T20:26:31Z
format Article
id doaj.art-529a901bebbd4ce1ae20e8c00da6da94
institution Directory Open Access Journal
issn 1818-8338
language Russian
last_indexed 2024-04-09T20:26:31Z
publishDate 2019-04-01
publisher ABV-press
record_format Article
series Klinicist
spelling doaj.art-529a901bebbd4ce1ae20e8c00da6da942023-03-30T20:14:10ZrusABV-pressKlinicist1818-83382019-04-01123-4212910.17650/1818-8338-2019-12-3-4-21-29306Analysis of adverse reactions of antihypertensive drugs registered in the Republic of Crimea for the period 2011-2016A. V. Matveev0A. E. Krasheninnikov1E. A. Egorova2A. G. Dormidor3ANO NationalPharmacovigilance Research Center; Medical Academy named after S.I. Georgievsky, V.I. Vernadsky Crimean Federal UniversityANO NationalPharmacovigilance Research CenterMedical Academy named after S.I. Georgievsky, V.I. Vernadsky Crimean Federal UniversityCenter of the Blood Circulation PathologyThe aim of study was to analyze and investigate the severity of adverse reactions (AR) on drugs used for arterial hypertension treatment in patients living in the Republic of Crimea for the period 2011—2016.Materials and methods. We studied notification cards about AR registered in the regional database of spontaneous messages ARCADe. We analyzed 211 notification cards about AR in patients with proven arterial hypertension diagnosis (ICD code П0—П5).Results. Drugs from the groups of angiotensin-converting enzyme inhibitors and slow calcium channel blockers most often cause AR, among them enalapril and amlodipine are the absolute leaders. AR occurred less frequently in application of drugs from the groups of в-blockers and angiotensin IIreceptor blockers. The study of the clinical manifestations of AR showed that most of them were allergic reactions of varying severity (skin itch, urticaria, swelling of lips, eyelids, tongue). The number of such cases was 70 (33.2 %) from all registered cases of AR on antihypertensive drugs. Examination of the outcomes of AR in patients taking antihypertensive drugs showed that the development of temporary disability was observed in 19 (9 %) cases, the hospitalization of outpatients as a result of AR development on drugs was required in 7 (3.3 %) cases, and in 2 cases patients had to prolong hospitalization. Life-threatening conditions in the form of Quincke’s edema were reported in 13patients. In the remaining 170 (80.6 %) cases AR were not serious and did not cause the above consequences. Assessment of AR severity revealed that mild AR were most common, much less often antihypertensive drugs caused severe AR (the incidence ranged from 5 to 13 %, depending on the method for severity assessment).Conclusion. The obtained results confirm our previously published data that in the structure of AR on antihypertensive drugs, bulk of the reports associated with angiotensin-converting enzyme inhibitors. Most often antihypertensive drugs caused mild AR.https://klinitsist.abvpress.ru/Klin/article/view/367adverse reactionsnotification cards about adverse reactionarterial hypertensionantihypertensive drugsangiotensinconverting enzyme inhibitorsslow calcium channel blockersf-blockersallergic reactionskarch—lasagni methodlds point scalehartwig—siegel criteria
spellingShingle A. V. Matveev
A. E. Krasheninnikov
E. A. Egorova
A. G. Dormidor
Analysis of adverse reactions of antihypertensive drugs registered in the Republic of Crimea for the period 2011-2016
Klinicist
adverse reactions
notification cards about adverse reaction
arterial hypertension
antihypertensive drugs
angiotensinconverting enzyme inhibitors
slow calcium channel blockers
f-blockers
allergic reactions
karch—lasagni method
lds point scale
hartwig—siegel criteria
title Analysis of adverse reactions of antihypertensive drugs registered in the Republic of Crimea for the period 2011-2016
title_full Analysis of adverse reactions of antihypertensive drugs registered in the Republic of Crimea for the period 2011-2016
title_fullStr Analysis of adverse reactions of antihypertensive drugs registered in the Republic of Crimea for the period 2011-2016
title_full_unstemmed Analysis of adverse reactions of antihypertensive drugs registered in the Republic of Crimea for the period 2011-2016
title_short Analysis of adverse reactions of antihypertensive drugs registered in the Republic of Crimea for the period 2011-2016
title_sort analysis of adverse reactions of antihypertensive drugs registered in the republic of crimea for the period 2011 2016
topic adverse reactions
notification cards about adverse reaction
arterial hypertension
antihypertensive drugs
angiotensinconverting enzyme inhibitors
slow calcium channel blockers
f-blockers
allergic reactions
karch—lasagni method
lds point scale
hartwig—siegel criteria
url https://klinitsist.abvpress.ru/Klin/article/view/367
work_keys_str_mv AT avmatveev analysisofadversereactionsofantihypertensivedrugsregisteredintherepublicofcrimeafortheperiod20112016
AT aekrasheninnikov analysisofadversereactionsofantihypertensivedrugsregisteredintherepublicofcrimeafortheperiod20112016
AT eaegorova analysisofadversereactionsofantihypertensivedrugsregisteredintherepublicofcrimeafortheperiod20112016
AT agdormidor analysisofadversereactionsofantihypertensivedrugsregisteredintherepublicofcrimeafortheperiod20112016